EUVIMEDEUVIMED entdecken
Crossref

SARS‐CoV‐2 Infection Reactivates HIV‐1 Replication From Latency in U1 Cells

Xue Wang iD, Weichun Tang, Jiangqin Zhao, Zhiping Ye, Hang Xie, Indira Hewlett

Journal of Cellular Physiology · 2025

DOI: 10.1002/jcp.70049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2025. Verfasst von Xue Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Silver Spring, Maryland, USA. Hauptthemen laut MEDLINE: HIV-1, Virus Replication, Virus Latency, SARS-CoV-2. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global impact of COVID‐19, caused by SARS‐CoV‐2, has infected millions, including those with HIV‐1. However, it is unclear if SARS‐CoV‐2 affects HIV‐1 reactivation from latency. Here, we used the U1 cell line to explore how SARS‐CoV‐2 infection affects HIV‐1 reactivation from latency, employing real‐time PCR assays and Western blot analysis. Our results show higher levels of HIV‐1 RNA after SARS‐CoV‐2 infection. Importantly, we noticed enhanced reactivation of HIV‐1 replication in cells infected with viruses carrying a deletion of amino acids R 682 , R 683 , A 684 (RRAΔ) in the spike (S) protein, compared to infections with viruses carrying the wild‐type S protein. This is involvement of host transcription factors like NFAT, NF‐κB p65, Ap‐1, and Sp‐1, which facilitate HIV production via TCR‐related pathways. Additionally, activation of p‐TEFb pathways enhances transcription elongation, upregulates Jak/Stat pathways, leading to increased viral replication, while TLR pathways impact the host immune response. Furthermore, RRAΔ showed increased apoptotic activity through both extrinsic and intrinsic apoptotic signaling pathways compared to wild‐type SARS‐CoV‐2. These indicate that SARS‐CoV‐2 infection could revive HIV‐1 replication from latency. The deletion of amino acids R 682 R 683 A 684 in the viral S protein might regulate further HIV‐1 replication and apoptotic conditions, potentially benefiting HIV‐1 survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Virus ReplicationVirus LatencySARS-CoV-2COVID-19Virus ActivationHIV InfectionsHumansCell LineSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

COVID‐19HIV‐1SARS‐CoV‐2U1 cellsfurinlatency

Substanzen

Spike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Xue Wang

Zitieren

APA

Wang, X., Tang, W., Zhao, J., Ye, Z., Xie, H., & Hewlett, I. (2025). SARS‐CoV‐2 Infection Reactivates HIV‐1 Replication From Latency in U1 Cells. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.70049

Vancouver

Wang X, Tang W, Zhao J, Ye Z, Xie H, Hewlett I. SARS‐CoV‐2 Infection Reactivates HIV‐1 Replication From Latency in U1 Cells. Journal of Cellular Physiology. 2025. doi:10.1002/jcp.70049

BibTeX
@article{Wang2025,
  author = {Wang, Xue and Tang, Weichun and Zhao, Jiangqin and Ye, Zhiping and Xie, Hang and Hewlett, Indira},
  title = {SARS‐CoV‐2 Infection Reactivates HIV‐1 Replication From Latency in U1 Cells},
  journal = {Journal of Cellular Physiology},
  year = {2025},
  doi = {10.1002/jcp.70049}
}
Kostenlos starten →